ResMed advances sleep and respiratory health in Singapore

ResMed, the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, has reaffirmed its commitment to expanding the company’s Singapore operations. ResMed continues to drive innovation in sleep and respiratory health worldwide, aligning with Singapore’s vision to be a leading hub for medical technology and advanced manufacturing.

ResMed will make new investments in Singapore by 2029, strengthening its global manufacturing network and positioning its Singapore presence as a key innovation hub for digital sleep health devices across the Asia-Pacific. In partnership with the Singapore Economic Development Board (EDB), ResMed will expand production capacity, drive advanced manufacturing process innovation, and support the growth of its Digital Science and Artificial Intelligence (AI) Lab (DSAIL), a strategic center that leverages AI, machine learning, and related technologies to enhance patient and physician experiences.

This partnership underscores Singapore's alignment with ResMed’s 2030 strategy and broader efforts to anchor innovation and talent development activities in areas including AI, supply chain development, and sustainability to drive economic growth.

Since establishing operations in Singapore more than 20 years ago, ResMed has significantly expanded its presence, now employing 1,300 people in the country. In 2022, the company opened its 270,000-square-foot Advanced Manufacturing Centre in Tuas. This state-of-the-art facility is ResMed’s largest manufacturing facility globally, and further, it is the biggest advanced manufacturing plant in the world dedicated to respiratory medical devices, masks, and beyond. It is equipped to scale the production of ResMed’s connected devices and mask systems, supporting sleep, respiratory health, and overall wellness. The facility includes the manufacturing of the AirSense 11, ResMed’s new innovative CPAP device, launched in Singapore on November 6.

Complementing this manufacturing hub is ResMed’s 3,400-square-foot Product Development Laboratory and regional commercial office in One North, which drive innovation and market growth across Asia, including the development of new products.

In addition to its manufacturing hub and research contributions, ResMed actively engages with local educational institutions and the government to improve the talent pool, supporting the needs of the expanding healthcare sector.